These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17537736)

  • 41. The effects of the Brazilian regulatory inspection programme on nuclear medicine facilities.
    Alves CE; Azevedo EM; de Sá LV; da Rosa LA; Mendes LC; França WF; Gutterres RF; Gonçalves M
    J Radiol Prot; 2009 Dec; 29(4):507-17. PubMed ID: 19923641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive quality assurance in medical use and a standard of care; correction--NRC. Advance notice of proposed rulemaking: withdrawal; correction.
    Fed Regist; 1998 Dec; 63(240):69026. PubMed ID: 10338888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NRC proposed amendments: too little, too late?
    Newman MA
    J Nucl Med; 1993 Sep; 34(9):25N. PubMed ID: 8355088
    [No Abstract]   [Full Text] [Related]  

  • 44. Instrumentation and radiopharmaceutical validation.
    Zigler SS
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):402-10. PubMed ID: 19834450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SNM general and hybrid imaging guidelines.
    Delbeke D
    J Nucl Med; 2010 Dec; 51(12):14N. PubMed ID: 21098786
    [No Abstract]   [Full Text] [Related]  

  • 46. Emerging technologies in radiation oncology and nuclear medicine: an overview of their use and regulation.
    Foens C
    J Am Coll Radiol; 2004 Sep; 1(9):619-23. PubMed ID: 17411667
    [No Abstract]   [Full Text] [Related]  

  • 47. Nuclear Regulatory Commission revises medical policy statement.
    J Nucl Med; 2000 Oct; 41(10):9N. PubMed ID: 11037983
    [No Abstract]   [Full Text] [Related]  

  • 48. Updates on practice and regulatory issues.
    Cannon H
    J Nucl Med; 2009 Apr; 50(4):19N. PubMed ID: 19339671
    [No Abstract]   [Full Text] [Related]  

  • 49. Strengthening radiopharmacy practice in IAEA Member States.
    Duatti A; Bhonsle U
    Semin Nucl Med; 2013 May; 43(3):188-94. PubMed ID: 23561456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The AAPM should develop protocols generically, and avoid documents that are too strict and prescriptive, to facilitate their adoption by regulatory agencies like the Nuclear Regulatory Commission and States.
    Jones CG; Thomadsen B
    Med Phys; 2000 Mar; 27(3):431-3. PubMed ID: 10757592
    [No Abstract]   [Full Text] [Related]  

  • 51. Exemption of radiopharmaceuticals from <797>.
    Hung JC; VanBrocklin HF
    J Nucl Med; 2004 Oct; 45(10):14N. PubMed ID: 15551510
    [No Abstract]   [Full Text] [Related]  

  • 52. Regulatory issues are primary focus for nuclear medicine groups.
    Nichols D
    J Nucl Med; 1997 Feb; 38(2):17N. PubMed ID: 9025728
    [No Abstract]   [Full Text] [Related]  

  • 53. CGMP for PET drugs: important steps to take now.
    Vanbrocklin H; Schwarz S
    J Nucl Med; 2010 Dec; 51(12):17N. PubMed ID: 21098789
    [No Abstract]   [Full Text] [Related]  

  • 54. The Energy Department's modest proposal.
    Rojas-Burke J
    J Nucl Med; 1993 Apr; 34(4):13N-14N, 17N-18N. PubMed ID: 8455069
    [No Abstract]   [Full Text] [Related]  

  • 55. Limited revision of fee schedules--NRC. Final rule.
    Fed Regist; 1992 Apr; 57(75):13625-34. PubMed ID: 10118460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of Radioactive Substances Advisory Committee.
    Nucl Med Commun; 2000 Jan; 21 Suppl():S1-93. PubMed ID: 10732169
    [No Abstract]   [Full Text] [Related]  

  • 57. Petition would ease strictures on outpatient nuclear medicine therapy.
    Rojas-Burke J
    J Nucl Med; 1992 Jul; 33(7):13N-14N. PubMed ID: 1613568
    [No Abstract]   [Full Text] [Related]  

  • 58. Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD).
    Chiti A
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2174. PubMed ID: 25143074
    [No Abstract]   [Full Text] [Related]  

  • 59. NRC final rule on expanded definition of byproduct material.
    J Nucl Med; 2007 Jun; 48(6):15N. PubMed ID: 17536100
    [No Abstract]   [Full Text] [Related]  

  • 60. Supervising nuclear medicine procedures: who, how, and how often.
    Eur J Nucl Med; 1998 Mar; 25(3):313-4. PubMed ID: 9580865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.